Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Mayo Clin Proc. 2023 Jun;98(6):883-891. doi: 10.1016/j.mayocp.2022.12.013. Epub 2023 Mar 13.
To describe the incidence, risk factors, and outcomes of incident atrial fibrillation (AF) in Graves disease (GD).
Patients with GD between January 1, 2009, and December 31, 2019, were included retrospectively. We defined GD-related AF as AF diagnosed less than or equal to 30 days before or any time after GD. Late-onset AF was defined as incident AF diagnosed more than 90 days after GD.
Of 1371 patients with GD, AF occurred in 139 patients. Late-onset AF occurred in 32 (23.0%) of AF cases, of which 16 (50.0%) had attained euthyroidism. Independent risk factors were age (HR, 1.05; 95% CI, 1.03-1.06 per year), overt hyperthyroidism (free T4 >1.7 ng/dL; HR, 2.75; 95% CI, 1.38 to 5.46), and male sex (HR, 2.30; 95% CI, 1.54 to 3.43) for early AF. These were age (HR, 1.08; 95% CI, 1.05 to 1.119 per year), chronic obstructive pulmonary disease (HR, 3.47; 95% CI, 1.36 to 5.54), and heart failure (HR, 5.86; 95% CI, 2.39 to 14.38) for late AF. Atrial fibrillation in GD was associated with higher mortality (HR, 16.32; 95% CI, 4.66 to 56.58), acute coronary syndrome/stable angina events (HR, 3.89; 95% CI, 1.23 to 12.31), and cardiac hospitalizations (HR, 15.39; 95% CI, 8.17 to 29.00) when adjusted to age, sex, and pre-existing AF.
Late-onset AF comprised one-quarter of GD-related AF cases requiring surveillance even after restoring euthyroidism. Risk factors for AF in GD are similar to those in the general population although overt hyperthyroidism conferred the highest risk, especially for early AF. Treatment with thionamide was associated with late AF.
描述格雷夫斯病(GD)患者中新发心房颤动(AF)的发生率、危险因素和结局。
回顾性纳入 2009 年 1 月 1 日至 2019 年 12 月 31 日期间的 GD 患者。我们将 GD 相关的 AF 定义为在 GD 确诊前或确诊后 30 天内诊断的 AF。迟发性 AF 定义为在 GD 确诊后 90 天以上诊断的新发 AF。
在 1371 例 GD 患者中,有 139 例发生了 AF。在 139 例 AF 中,迟发性 AF 占 32 例(23.0%),其中 16 例(50.0%)已达到甲状腺功能正常。早发性 AF 的独立危险因素包括年龄(HR,1.05;95%CI,每年 1.03-1.06)、显性甲状腺功能亢进(游离 T4>1.7ng/dL;HR,2.75;95%CI,1.38-5.46)和男性(HR,2.30;95%CI,1.54-3.43)。迟发性 AF 的危险因素包括年龄(HR,1.08;95%CI,每年 1.05-1.119)、慢性阻塞性肺疾病(HR,3.47;95%CI,1.36-5.54)和心力衰竭(HR,5.86;95%CI,2.39-14.38)。GD 合并 AF 与死亡率增加(HR,16.32;95%CI,4.66-56.58)、急性冠状动脉综合征/稳定型心绞痛事件(HR,3.89;95%CI,1.23-12.31)和心脏住院(HR,15.39;95%CI,8.17-29.00)相关,这些事件在调整年龄、性别和既往 AF 后仍存在。
即使在恢复甲状腺功能正常后,迟发性 AF 仍占 GD 相关 AF 病例的四分之一,需要监测。GD 中 AF 的危险因素与普通人群相似,尽管显性甲状腺功能亢进症风险最高,尤其是早发性 AF。用硫脲类药物治疗与迟发性 AF 相关。